These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3314882)

  • 21. [In vitro characterization of S9788, a new modulator of multidrug resistance].
    Pérez V; Pierré A; Léonce S; Anstett M; Prost JF; Atassi G
    Bull Cancer; 1993 Apr; 80(4):310-25. PubMed ID: 8173185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.
    Sugawara I; Kataoka I; Morishita Y; Hamada H; Tsuruo T; Itoyama S; Mori S
    Cancer Res; 1988 Apr; 48(7):1926-9. PubMed ID: 2894894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
    Yang JM; Goldenberg S; Gottesman MM; Hait WN
    Cancer Res; 1994 Feb; 54(3):730-7. PubMed ID: 7905786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
    Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA
    Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of action and resistance of antineoplastic agents].
    Tanaka N
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2245-51. PubMed ID: 6195971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multiple drug resistance of tumor cells: manifestations, genetic basis, clinical aspects].
    Gudkov AV
    Mol Gen Mikrobiol Virusol; 1987 Aug; (8):3-9. PubMed ID: 3317023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cross and non-cross resistant anticancer agents to multidrug-resistant cultured cells from hematologic malignancies].
    Shimoyama M; Ishida Y; Ohtsu T; Shimada Y; Tobinai K; Minato K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1273-9. PubMed ID: 2730025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
    Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
    Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance.
    Leveille-Webster CR; Arias IA
    Clin Cancer Res; 1996 Apr; 2(4):695-706. PubMed ID: 9816220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity.
    Fichtner I; Stein U; Hoffmann J; Winterfeld G; Pfeil D; Hentschel M
    Anticancer Res; 1994; 14(5A):1995-2003. PubMed ID: 7847840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen aziridine, a novel affinity probe for P-glycoprotein in multidrug resistant cells.
    Safa AR; Roberts S; Agresti M; Fine RL
    Biochem Biophys Res Commun; 1994 Jul; 202(1):606-12. PubMed ID: 7913604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
    Van Acker KL; Van Hove LM; Boogaerts MA
    Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity.
    Bech-Hansen NT; Till JE; Ling V
    J Cell Physiol; 1976 May; 88(1):23-31. PubMed ID: 57118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms and clinical significance of multidrug resistance.
    Morrow CS; Cowan KH
    Oncology (Williston Park); 1988 Oct; 2(10):55-63, 66-8. PubMed ID: 3079288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular mechanisms of multidrug resistance].
    Tsuruo T
    Tanpakushitsu Kakusan Koso; 1987 Nov; 32(12):1400-12. PubMed ID: 2894042
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug resistance and a strategy to eradicate resistant malignant cells].
    Shimoyama M
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1280-2. PubMed ID: 2730026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance.
    Sakata K; Kwok TT; Murphy BJ; Laderoute KR; Gordon GR; Sutherland RM
    Br J Cancer; 1991 Nov; 64(5):809-14. PubMed ID: 1681885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of crossed resistance of neoplastic cells with high level of colchicine resistance].
    Abdriashitov RI; Stavrovskaia AA
    Biull Eksp Biol Med; 1989 Oct; 108(10):490-2. PubMed ID: 2597770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of actinomycin-D-resistant CHO cell lines exhibiting a multidrug-resistance phenotype and amplified DNA sequences.
    Diddens H; Gekeler V; Neumann M; Niethammer D
    Int J Cancer; 1987 Nov; 40(5):635-42. PubMed ID: 2445701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleiotropic phenotype of cultured murine cells resistant to maytansine, vincristine, colchicine, and adriamycin.
    Aldrich CD
    J Natl Cancer Inst; 1979 Sep; 63(3):751-7. PubMed ID: 224236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.